News
MP0726, a Radio-DARPin candidate targeting mesothelin (MSLN) and intended for the treatment of ovarian cancer, is nominated for development under strategic partnership with Orano Med The oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback